Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD8+CD28-CD127loCD39+ regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?
Fenoglio D, Dentone C, Signori A, Di Biagio A, Parodi A, Kalli F, Nasi G, Curto M, Cenderello G, De Leo P, Bartolacci V, Orofino G, Nicolini LA, Taramasso L, Fiorillo E, Orrù V, Traverso P, Bruzzone B, Ivaldi F, Mantia E, Guerra M, Negrini S, Giacomini M, Bhagani S, Filaci G. Fenoglio D, et al. Among authors: kalli f. J Allergy Clin Immunol. 2018 Jun;141(6):2220-2233.e4. doi: 10.1016/j.jaci.2017.08.021. Epub 2017 Nov 2. J Allergy Clin Immunol. 2018. PMID: 29103633 Free article.
Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells.
Traverso I, Fenoglio D, Negrini S, Parodi A, Battaglia F, Kalli F, Conteduca G, Tardito S, Traverso P, Indiveri F, Filaci G. Traverso I, et al. Among authors: kalli f. Hum Immunol. 2012 Mar;73(3):207-13. doi: 10.1016/j.humimm.2011.12.020. Epub 2012 Jan 14. Hum Immunol. 2012. PMID: 22285846 Free article.
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.
Parodi A, Battaglia F, Kalli F, Ferrera F, Conteduca G, Tardito S, Stringara S, Ivaldi F, Negrini S, Borgonovo G, Simonato A, Traverso P, Carmignani G, Fenoglio D, Filaci G. Parodi A, et al. Among authors: kalli f. Cancer Immunol Immunother. 2013 May;62(5):851-62. doi: 10.1007/s00262-013-1392-z. Epub 2013 Jan 29. Cancer Immunol Immunother. 2013. PMID: 23359087 Free PMC article.
Fingolimod modulates peripheral effector and regulatory T cells in MS patients.
Serpero LD, Filaci G, Parodi A, Battaglia F, Kalli F, Brogi D, Mancardi GL, Uccelli A, Fenoglio D. Serpero LD, et al. Among authors: kalli f. J Neuroimmune Pharmacol. 2013 Dec;8(5):1106-13. doi: 10.1007/s11481-013-9465-5. Epub 2013 May 7. J Neuroimmune Pharmacol. 2013. PMID: 23649711 Free PMC article.
Generation of more effective cancer vaccines.
Fenoglio D, Traverso P, Parodi A, Kalli F, Zanetti M, Filaci G. Fenoglio D, et al. Among authors: kalli f. Hum Vaccin Immunother. 2013 Dec;9(12):2543-7. doi: 10.4161/hv.26147. Epub 2013 Aug 26. Hum Vaccin Immunother. 2013. PMID: 23978951 Free PMC article.
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL.
Dentone C, Fenoglio D, Signori A, Cenderello G, Parodi A, Bozzano F, Guerra M, De Leo P, Bartolacci V, Mantia E, Orofino G, Kalli F, Marras F, Fraccaro P, Giacomini M, Cassola G, Bruzzone B, Ferrea G, Viscoli C, Filaci G, De Maria A, Di Biagio A. Dentone C, et al. Among authors: kalli f. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19718. doi: 10.7448/IAS.17.4.19718. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397464 Free PMC article.
26 results